Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haloperidol in palliative care.

Jane Vella-Brincat1, A D Macleod

  • 1Nurse Maude Hospice, Christchurch, New Zealand. janevb@cdhb.govt.nz

Palliative Medicine
|June 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early constipation predicts faster dementia onset in Parkinson's disease.

NPJ Parkinson's disease·2021
Same author

Patient characteristics, treatment outcomes and rehabilitation practices for patients admitted with hip fractures using multiple data set analysis.

The New Zealand medical journal·2020
Same author

Three-month use of idarucizumab at Christchurch Hospital through the emergency department and MedChartTM.

The New Zealand medical journal·2019
Same author

Untangling chronic pain and post-concussion symptoms: the significance of depression.

Brain injury·2018
Same author

Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls.

Parkinsonism & related disorders·2016
Same author

Motor complications in an incident Parkinson's disease cohort.

European journal of neurology·2015
Same journal

Understanding workplace peer support among healthcare assistants providing palliative and end-of-life care at home: A realist review.

Palliative medicine·2026
Same journal

Exploring Pathways to Optimise Care in malignant bowel obstruction (EPOC): A realist review of shared decision-making with people with advanced cancer and severe symptoms.

Palliative medicine·2026
Same journal

Caregivers' perspectives on family meetings and preparedness for imminent death: A qualitative descriptive study in a palliative care setting.

Palliative medicine·2026
Same journal

Palliative care: The holy grail of healthcare interventions?

Palliative medicine·2026
Same journal

Social determinants of death anxiety in patients with advanced cancer receiving outpatient palliative care.

Palliative medicine·2026
Same journal

A Reflexivity Lab as a methodological tool in end-of-life research.

Palliative medicine·2026
See all related articles

Haloperidol is essential in palliative care for nausea, vomiting, and delirium. Understanding its complex pharmacology and administration routes is crucial for managing adverse effects like extrapyramidal symptoms (EPS).

Area of Science:

  • Palliative Care Pharmacology
  • Neuroleptic Drug Therapeutics

Background:

  • Haloperidol is a key medication in palliative care.
  • Its complex pharmacology and adverse effects require careful consideration.

Purpose of the Study:

  • To provide a comprehensive review of haloperidol in palliative care.
  • To detail indications, dosing, pharmacology, and adverse effects.

Main Methods:

  • Literature review on haloperidol use in palliative care.
  • Analysis of pharmacology, indications, and adverse effects.

Main Results:

  • Common indications include nausea, vomiting, and delirium.
  • Adverse effects include extrapyramidal adverse effects (EPS) and QT prolongation.

Related Experiment Videos

  • Sedation is not a common side effect.

    • Conclusions:

    • Palliative care practitioners need a thorough understanding of haloperidol.
    • Route of administration may influence the severity of adverse effects like EPS.